| Overview |
| bsm-90015R |
| Phospho-DNA PKcs (S2056) Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Phospho-DNA PKcs (S2056) |
| 2049-2063/4128 |
| Monoclonal |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 5591 |
| P78527 |
| PRKDC; Protein Kinase DNA-Activated Catalytic Subunit; DNPK1; P460; DNA-Dependent Protein Kinase Catalytic Subunit; DNA-PKcs; DNA-PKC; DNAPK; XRCC7; HYRC1; P350; HYRC; Protein Kinase DNA-Activated Catalytic Polypeptide; DNA-PK Catalytic Subunit; EC 2.7.11.1; DNAPKc; Hyper-Radiosensitivity Of Murine Scid Mutation Complementing 1; DNA-PKCS; DNAPKC; IMD26 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz